Isosorbide Mononitrate Dosing for Cardiovascular Disease
For heart failure with reduced ejection fraction (HFrEF), isosorbide mononitrate is NOT used as monotherapy—instead, use the fixed-dose combination of isosorbide dinitrate 20-40 mg with hydralazine 37.5-75 mg three times daily, starting at the lower dose and titrating to the target dose. 1, 2
Heart Failure Indications and Dosing
Primary Indication: HFrEF in African American Patients
- The combination of isosorbide dinitrate/hydralazine is specifically recommended for African American patients with symptomatic HFrEF who remain symptomatic despite optimal guideline-directed medical therapy. 1, 3
- This combination provides a 43% relative risk reduction in mortality with a number needed to treat of only 7 patients over 36 months. 1, 3
- Start with 20 mg isosorbide dinitrate/37.5 mg hydralazine three times daily. 1, 2
- Target dose: 40 mg isosorbide dinitrate/75 mg hydralazine three times daily. 1, 2
- Maximum daily dose: 120 mg isosorbide dinitrate/225 mg hydralazine total. 1, 3
Alternative Indication: ACE Inhibitor/ARB Intolerance
- Use isosorbide dinitrate/hydralazine combination in patients with symptomatic HFrEF who cannot tolerate ACE inhibitors or ARBs due to hypotension, renal insufficiency, or drug intolerance. 3
- Do NOT substitute this combination for ACE inhibitors/ARBs in patients tolerating those medications well. 3
Acute Heart Failure
- In acute heart failure with systolic blood pressure >110 mmHg, intravenous nitrates (including isosorbide mononitrate) can be used. 4
- Initial IV nitroglycerin dose: 10-20 mcg/min, increased by 5-10 mcg/min every 3-5 minutes as needed. 4
- Avoid all vasodilators including nitrates when systolic blood pressure <90 mmHg as this may reduce central organ perfusion. 4
Hypertension Considerations
Isosorbide mononitrate is NOT a first-line or recommended agent for hypertension management. 5
- For resistant hypertension, the treatment algorithm prioritizes renin-angiotensin system blockers, calcium channel blockers, and diuretics before considering other agents. 5
- Hydralazine (used with isosorbide dinitrate in HF) appears only at Step 5 of resistant hypertension management, and specifically requires concomitant beta-blocker and diuretic use. 5
- In resistant hypertension with congestive heart failure with reduced ejection fraction, hydralazine should be administered with isosorbide mononitrate 30 mg daily (maximum 90 mg daily). 5
Monotherapy Dosing (When Appropriate)
If isosorbide mononitrate extended-release is used as monotherapy (primarily for angina, not heart failure):
- Starting dose: 30 mg once daily in the morning. 6
- May increase to 60 mg once daily after several days. 6
- Maximum dose: 120 mg once daily (rarely 240 mg may be required). 6
- Take in the morning on arising; do not chew or crush tablets. 6
Tolerance Prevention Strategy
- A daily nitrate-free interval of at least 14 hours is essential to prevent tolerance development. 7
- Tolerance becomes clinically relevant after 24 hours of continuous therapy. 7
- Once-daily dosing in the morning naturally provides this nitrate-free interval overnight. 8
- For conventional (non-extended release) formulations: 20 mg twice daily with doses separated to allow a nitrate-free interval. 7, 9
Critical Safety Considerations
Absolute Contraindications
- Never use isosorbide mononitrate or isosorbide dinitrate with phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil) due to risk of profound hypotension. 3, 10
Blood Pressure Monitoring
- Monitor blood pressure and heart rate closely, especially during dose titration. 3, 10
- Use particular caution in elderly patients or those on multiple antihypertensive medications. 10
- Patients with aortic stenosis may demonstrate marked hypotension following nitrate initiation. 4
Common Adverse Effects
- Headache is the most frequent side effect (7.7% in first week, decreasing to 0.9% after 24 weeks). 11
- Hypotension may occur, particularly with IV formulations or when combined with other vasodilators. 4
- Tachyphylaxis is common after 24-48 hours with continuous dosing, necessitating dose-free intervals. 4
Clinical Pitfalls to Avoid
Do not use isosorbide mononitrate alone for heart failure—the evidence supports only the combination with hydralazine, specifically using isosorbide dinitrate (not mononitrate). 1, 2
Do not dose nitrates three or more times daily without a nitrate-free interval—this rapidly induces tolerance and loss of efficacy. 8, 9
Do not use calcium antagonists in acute heart failure management—they are not recommended. 4
Do not continue nitrates if systolic blood pressure drops below 90 mmHg—this compromises organ perfusion. 4